01163-7/asset/f29611d8-43e0-475b-8d92-bab260b93b12/main.assets/gr2_lrg.jpg)
cagrilintide tirzepatide combination trial Efficacy and safety of co-administered once-weekly 2·4 mg with once-weekly semaglutide 2·4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 Cagrilintide–semaglutide (CagriSema) versus semaglutide or
Description
Learn more about Joey Meds GLP-1 program.
00125-7/asset/c8ecd4ec-8b7c-48e1-bb82-1c56292e9cbf/main.assets/gr3_lrg.jpg)
My take: GLP-1RAs may become more than metabolic drugs, but oncology needs prospective cancer-outcome data before calling this prevention
Call Walk In
Tirzepatide reduces hunger and slows stomach emptying, making meal timing and composition critical for success
GLP-1 medications may be used by individuals without a gallbladder, but require careful medical evaluation
Why This Matters: This isn't just a win for the industry
